Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EC Considers API Regulation In Effort To Fight Counterfeit Drugs

Executive Summary

Stricter requirements for active ingredients, a ban on repackaging, and mandatory company audits of their trading partners are on the table in the European Commission's quest for antidotes to a growing influx of counterfeit medicines

You may also be interested in...



EU Tackles Counterfeits, But Parallel Trade Poses Tough Issues

Tackling counterfeit drugs is one pillar of the European Commission's package of new proposed pharmaceutical legislation. It will mean higher costs for most drug firms, while significant loopholes will remain

EU Tackles Counterfeits, But Parallel Trade Poses Tough Issues

Tackling counterfeit drugs is one pillar of the European Commission's package of new proposed pharmaceutical legislation. It will mean higher costs for most drug firms, while significant loopholes will remain

EU Drug Makers Tackle Traceability With Pharmacy Verification Pilot Project

The European Federation of Pharmaceutical Industries and Associations is spearheading a project to develop an end-to-end verification system for individual packages of medications

Related Content

UsernamePublicRestriction

Register

PS049555

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel